Evaluation of Bone Metabolism Biomarkers in Paget's Disease of Bone

Objective: To evaluate serum levels of bone metabolism biomarkers in patients with Paget's disease of bone (PDB). Methods: Serum levels of osteopontin, sclerostin, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin, Dickkopf-related protein 1 (DKK-1), and soluble frizz...

Descripción completa

Detalles Bibliográficos
Autores principales: Werner de Castro, Glaucio R, Buss, Ziliani Da Silva, Rosa, Julia Salvan, Facchin, Bruno M, Fröde, Tania S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679708/
https://www.ncbi.nlm.nih.gov/pubmed/31384515
http://dx.doi.org/10.7759/cureus.4791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679708/
https://www.ncbi.nlm.nih.gov/pubmed/31384515
http://dx.doi.org/10.7759/cureus.4791

Ejemplares similares